Table 4 –
Propensity score weighted multivariate analysis of long-term clinical outcomes compared with dual-goal and single-goal achievers.
| Complications/death | Ale + BP vs A1e | Ale + BP vs BP | A1e + LDL-C vs A1e | A1e + LDL-C vs LDL-C | LDL-C + BP vs LDL-C | LDL-C + BP vs BP | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| aHR* | 95% CI | aHR* | 95% CI | aHR* | 95% CI | aHR* | 95% CI | aHR* | 95% CI | aHR* | 95% CI | |
| Microvascular complications | 1.005 | (0.988, 1.021) | 0.996 | (0.983, 1.009) | 0.986 | (0.969, 1.003) | 1.008 | (0.993, 1.023) | 1.003 | (0.991, 1.016) | 0.973 | (0.962, 0.984) |
| Macrovascular complications | 0.996 | (0.980, 1.013) | 0.982 | (0.969, 0.995) | 0.974 | (0.958, 0.992) | 0.990 | (0.975, 1.005) | 1.000 | (0.988, 1.012) | 0.970 | (0.959, 0.981) |
| Myocardial infarction | 0.995 | (0.979, 1.011) | 0.988 | (0.976, 1.001) | 0.978 | (0.962, 0.995) | 1.000 | (0.985, 1.014) | 0.997 | (0.985, 1.009) | 0.969 | (0.959, 0.980) |
| Cerebrovascular disease | 0.999 | (0.983, 1.016) | 0.987 | (0.975, 1.000) | 0.978 | (0.961, 0.995) | 0.997 | (0.983, 1.011) | 1.001 | (0.989, 1.013) | 0.970 | (0.959, 0.981) |
| Acute coronary syndromes | 0.995 | (0.979, 1.011) | 0.989 | (0.977, 1.001) | 0.978 | (0.961, 0.994) | 0.999 | (0.985, 1.014) | 0.997 | (0.985, 1.008) | 0.970 | (0.959, 0.980) |
| Congestive heart failure | 0.994 | (0.978, 1.010) | 0.989 | (0.976, 1.001) | 0.975 | (0.959, 0.992) | 1.001 | (0.986, 1.015) | 0.998 | (0.986, 1.010) | 0.967 | (0.956, 0.978) |
| All-cause death | 0.996 | (0.980, 1.012) | 0.988 | (0.976, 1.001) | 0.978 | (0.962, 0.995) | 0.998 | (0.983, 1.012) | 0.995 | (0.984, 1.007) | 0.969 | (0.958, 0.980) |
*
aHR: Adjusted Hazard Ratio; compared with Triple-goal achievers to other goal achievement which were associated with higher risk for complications/all-cause mortality.